Eye-Catching Stocks: Lenovo Group Limited (ADR) (OTCMKTS:LNVGY), 22nd Century Group Inc (OTCBB:XXII), Transgenomic Inc (OTCMKTS:TBIO), Wynn Macau Ltd. (OTCMKTS:WYNMY)

Lewes, DE -- (SBWire) -- 10/08/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Lenovo Group Limited (ADR) (OTCMKTS:LNVGY), 22nd Century Group Inc (OTCBB:XXII), Transgenomic Inc (OTCMKTS:TBIO), Wynn Macau Ltd. (OTCMKTS:WYNMY).

Lenovo Group Limited (ADR) (OTCMKTS:LNVGY) opened its last trade at the price of $21.00. Its closing price was $21.13 after losing -0.66% for the day. The company traded with the total volume of 27.239 shares, while its average trading volume remained 148.608 shares. The beta of this stock stands at 1.54. Lenovo Group Limited, together with its subsidiaries, engages in the manufacture and distribution of IT products, and provision of IT services in worldwide.

Will LNVGY Get Buyers Even After The Recent Rally? Find Out Here

22nd Century Group Inc (OTCBB:XXII) percentage change plunged -4.80% to close at $1.19 with the total traded volume of 155.525 shares while its average volume of 291.381 shares. The 52 week range of the stock remained $0.15 - $1.74, while its day lowest price was $1.16. The share price hit the day highest price of $1.22. 22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.

Will XXII Get Buyers Even After The Recent Rally? Find Out Here

Transgenomic Inc (OTCMKTS:TBIO) traded on volume of 465.005 shares in the last session against average volume of 97.615 shares. The company started its trading session with the price of $0.50 and closed at $0.470 by scoring -6.00%. In the last three months the stock was up 11.9% while its 52 week range of the stock was $0.30 - $0.97. Transgenomic, Inc. operates as a biotechnology company in the United States, Italy, the United Kingdom, Germany, France, and internationally. Its Clinical Laboratories segment offers genetic testing services for cardiology, neurology, mitochondrial disorders, and oncology.

Will TBIO Get Buyers Even After The Recent Rally? Find Out Here

Wynn Macau Ltd. (OTCMKTS:WYNMY) started its last trading session with the price of $36.75 and closed at $36.85 by scoring 0.74%. The stock traded with total volume of 19.307 shares, while the average trading volume remained 14.200 shares. The beta value of this stock stands at 1.73. Day range for the stock was $36.75 and $36.90. Wynn Macau, Limited, through its subsidiaries, owns and operates the Wynn Macau resort in Macau.

Will WYNMY Continue To Move Higher? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/351879